These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1023 related items for PubMed ID: 22876370

  • 1.
    Golden SH, Brown T, Yeh HC, Maruthur N, Ranasinghe P, Berger Z, Suh Y, Wilson LM, Haberl EB, Bass EB.
    ; 2012 07. PubMed ID: 22876370
    [Abstract] [Full Text] [Related]

  • 2. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH, Sapir T.
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2009 Aug; 9(20):1-58. PubMed ID: 23074525
    [Abstract] [Full Text] [Related]

  • 5. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
    Thomas MG, Avari P, Godsland IF, Lett AM, Reddy M, Oliver N.
    Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
    [Abstract] [Full Text] [Related]

  • 6. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L.
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [Abstract] [Full Text] [Related]

  • 7. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N.
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [Abstract] [Full Text] [Related]

  • 8. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.
    Cochrane Database Syst Rev; 2012 Jan 18; 1(1):CD008101. PubMed ID: 22258980
    [Abstract] [Full Text] [Related]

  • 9.
    Yeh HC, Lau BD, Golden SH, Donner T, Brown TT, Bass EB.
    ; 2013 03 18. PubMed ID: 23905192
    [Abstract] [Full Text] [Related]

  • 10. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.
    Health Technol Assess; 2016 Feb 18; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [Abstract] [Full Text] [Related]

  • 11. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S, Smith-Palmer J, Valentine WJ, Cook M, Jethwa M, de Portu S, Pickup JC.
    J Med Econ; 2016 Feb 18; 19(3):236-42. PubMed ID: 26510389
    [Abstract] [Full Text] [Related]

  • 12. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I, Pala L, Caliri M, Minardi S, Cosentino C, Monami M, Mannucci E.
    Diabetes Obes Metab; 2020 Aug 18; 22(8):1286-1291. PubMed ID: 32166907
    [Abstract] [Full Text] [Related]

  • 13. RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta-analysis.
    William J, McCluskey J, Gleeson N.
    Endocrinol Diabetes Metab; 2022 Mar 18; 5(2):e00324. PubMed ID: 35118826
    [Abstract] [Full Text] [Related]

  • 14. Diabetes technology and treatments in the paediatric age group.
    Shalitin S, Peter Chase H.
    Int J Clin Pract Suppl; 2011 Feb 18; (170):76-82. PubMed ID: 21323816
    [Abstract] [Full Text] [Related]

  • 15. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J, Petruželková L, Grunberger G, Hásková A, Flekač M, Matoulek M, Mikeš O, Pelcl T, Škrha J, Horová E, Škrha J, Parkin CG, Svačina Š, Prázný M.
    Diabetes Care; 2020 Jan 18; 43(1):37-43. PubMed ID: 31530663
    [Abstract] [Full Text] [Related]

  • 16. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I, Mannucci E, Monami M, Pala L.
    Diabetes Obes Metab; 2019 Dec 18; 21(12):2619-2625. PubMed ID: 31368658
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J, Petruželková L, Flekač M, Pelcl T, Matoulek M, Daňková M, Škrha J, Svačina Š, Prázný M.
    Diabetes Technol Ther; 2016 Sep 18; 18(9):532-8. PubMed ID: 27482825
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E, Brennan P.
    JBI Libr Syst Rev; 2012 Sep 18; 10(42 Suppl):1-10. PubMed ID: 27820140
    [Abstract] [Full Text] [Related]

  • 19. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.
    Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV.
    Diabetes Care; 1999 Nov 18; 22(11):1779-84. PubMed ID: 10546007
    [Abstract] [Full Text] [Related]

  • 20. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S, Bonnemaison-Gilbert E, Leutenegger E, Barat P.
    Arch Pediatr; 2019 Feb 18; 26(2):95-101. PubMed ID: 30642746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.